Butterfly iQ, the world’s first single-probe whole body ultrasound system, will now be available for customers outside of the United States for the first time, setting the stage for more accessible and affordable medical imaging, globally.
Butterfly Network, announced that it has received CE Mark for Butterfly iQ, the world’s first handheld, single-probe whole body ultrasound system. Following CE Mark clearance, licensed medical professionals in the United Kingdom, Europe, Australia, and New Zealand can reserve Butterfly iQ to become one of the first customers outside of the United States to receive their device.
“We’re incredibly proud to achieve this significant milestone that will further our mission to democratize healthcare and bring medical imaging to the 4.7 billion people worldwide that currently lack access to this life saving technology,” said Gioel Molinari, President of Butterfly Network.
Since its introduction in 2018, Butterfly iQ has seen rapid adoption by thousands of physicians, EMTs, physician assistants, nurses and other practitioners in the United States. Butterfly’s CE Mark approval is a major step towards placing the device in the hands of 40 million healthcare workers globally, accelerating diagnosis and improving patient care.
Butterfly Network plans to begin shipping Butterfly iQ globally to markets that accept CE Mark as early as Summer 2019.
Related Reports and Monitors
Status of the Microfluidics Industry 2019
Market & Technology
Artificial Intelligence in Medical Diagnostics – Patent landscape analysis